High expression of HOXA4 in patients with glioma indicates unfavorable clinical outcomes

HOXA4 is a novel oncogene that has been observed in many kinds of tumors, but its role during glioma carcinogenesis and its clinical significance in diagnosing and prognosis human glioma remains unknown. In the present study, the Chinese Glioma Atlas (CGGA)-RNA sequencing database, CGGA microarray,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Zhenghong, Liu, Zhendong, Lian, Xiaoyu, Cheng, Xingbo, Liu, Binfeng, Zhang, Bo, Wang, Hongbo, Wang, Jialin, Li, Ang, Ren, Zhishuai, Pang, Bo, Qian, Rongjun, Gao, Yanzheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645261/
https://www.ncbi.nlm.nih.gov/pubmed/35852388
http://dx.doi.org/10.1080/15384101.2022.2096715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645261/
https://www.ncbi.nlm.nih.gov/pubmed/35852388
http://dx.doi.org/10.1080/15384101.2022.2096715

Ejemplares similares